Planta Med 2011; 77(1): 81-86
DOI: 10.1055/s-0030-1250132
Analytical Studies
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

Quality Assessment of Polygonum cuspidatum and Polygonum multiflorum by 1H NMR Metabolite Fingerprinting and Profiling Analysis

Michel Frédérich1 , Jean-Noël Wauters1 , Monique Tits1 , Charlotte Jason1 , Pascal de Tullio2 , Yvan Van der Heyden3 , Guorong Fan4 , Luc Angenot1
  • 1Drug Research Center (CIRM), Laboratory of Pharmacognosy, University of Liège, Liège, Belgium
  • 2Drug Research Center (CIRM), Laboratory of Medicinal Chemistry, University of Liège, Liège, Belgium
  • 3Faculteit Geneeskunde en Farmacie, Farmaceutisch Instituut, Dienst Analytische Scheikunde en Farmaceutische Technologie (FABI), VUB, Brussels, Belgium
  • 4School of Pharmacy, Second Military Medical University, Shanghai, P. R. China
Further Information

Publication History

received March 12, 2010 revised May 4, 2010

accepted June 17, 2010

Publication Date:
19 July 2010 (online)

Preview

Abstract

The quality assessment and control of traditional Chinese medicines (TCM) nowadays receives a great deal of attention worldwide and particularly in Europe with its increasing local use. Polygonum cuspidatum Siebold & Zucc. and Polygonum multiflorum Thunb. are two members of the Polygonaceae family, which are widely used as Chinese medicinal plants. The aim of this study was to achieve an overview of the quality of P. cuspidatum and P. multiflorum samples available on the Chinese market and to identify important metabolites for their discrimination, using 1H NMR-based metabolomics. 1H NMR and multivariate analysis techniques were applied to almost 60 plant samples collected in different places in China. Using 1H NMR metabolomics, it was possible, without previous evaporation or separation steps, to obtain metabolic fingerprints to distinguish between the species. The important metabolites for discrimination were stilbene derivatives. Finally, a clear distinction between the two species was possible and the discriminant metabolites were identified.

References

Dr. Michel Frédérich

Laboratory of Pharmacognosy
Drug Research Center (CIRM)
University of Liège

Avenue de l'Hôpital, 1, B36

4000 Liège

Belgium

Phone: + 32 43 66 43 31

Fax: + 32 43 66 43 32

Email: M.Frederich@ulg.ac.be